Enduro Genetics, a Copenhagen, Denmark -based biotech company, raised an undisclosed amount in funding.
The round was led by NOON Ventures.
The company intends to use the funds to expand operations and its development efforts.
Led by Peter Rugbjerg, CEO, Enduro Genetics is a technology provider committed to enabling large-scale fermentations. The company increases the competitiveness of current and future green bioproduction using its proprietary synthetic-biology technology – Enduro Sense – that self-selects the best cell variants. Spun out from the Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Enduro has incubated at the BioInnovation Institute in Copenhagen and received funding from the Innovation Fund Denmark.
In connection with the investment Enduro Genetics strengthens the board of directors. Former Novozymes EVP Thomas Videbæk and former Novozymes VP Ejner Bech Jensen joined the board. Former deputy CEO of the Novo Nordisk Foundation Niels Peder Nielsen becomes chairman.
FinSMEs
09/04/2022